Keywords: Blood Vessels, Permeability
Motivation: Evaluating intracranial aneurysm (IA) risk holds significant clinical importance. Recent studies have proposed wall permeability (Ktrans) as a significant risk predictor, but its validity in non-saccular aneurysms remains unclear.
Goal(s): Our study aims to predict non-saccular IA rupture by Ktrans from DCE-MRI.
Approach: Ktrans was derived from the extended Kety/Tofts model. We analyzed correlation between Ktrans and IA size, the Population, Hypertension, Age, Size, Earlier Subarachnoid Hemorrhage, and Site (PHASES) score and other clinical factors.
Results: Ktrans significantly related to IA size and PHASES score, but there was no correlation between Ktrans and intramural hematoma (IMH) and wall enhancement index (WEI).
Impact: By analyzing correlation between aneurysm wall permeability (Ktrans) and other risk factors of non-saccular aneurysms rupture, we found that Ktrans might be a risk indicator for rupture of non-saccular IAs.
1. Vlak, Monique HM, et al. "Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis." The Lancet Neurology 10.7 (2011): 626-636.
2. Van Gijn, Jan, Richard S. Kerr, and Gabriel JE Rinkel. "Subarachnoid haemorrhage." The Lancet 369.9558 (2007): 306-318.
3. Greving, Jacoba P., et al. "Development of the PHASES score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies." The Lancet Neurology 13.1 (2014): 59-66.
4. Sandhu, Harleen K., et al. "Outcomes and management of type A intramural hematoma." Annals of Cardiothoracic Surgery 5.4 (2016): 317.
5. Haikun, Qi, Peng Liu, and Huijun Chen. "Intracranial aneurysm wall permeability: a potential risk predictor for rupture." Proc. Intl. Soc. Mag. Reson. Med. Vol. 24. 2016.
6. Vakil, P., et al. "Quantifying intracranial aneurysm wall permeability for risk assessment using dynamic contrast-enhanced MRI: a pilot study." American Journal of Neuroradiology 36.5 (2015): 953-959.
7. Qi, H., et al. "Complementary roles of dynamic contrast-enhanced MR imaging and postcontrast vessel wall imaging in detecting high-risk intracranial aneurysms." American Journal of Neuroradiology 40.3 (2019): 490-496.
8. Kurtelius, Arttu, et al. "Association of intracranial aneurysms with aortic aneurysms in 125 patients with fusiform and 4253 patients with saccular intracranial aneurysms and their family members and population controls." Journal of the American Heart Association 8.18 (2019): e013277.
9. Yan, L., et al. "Predicting the Risk of Non-Saccular Aneurysms Based on the Dynamic Contrast-Enhanced Magnetic Resonance Imaging." ISMRM Annual Meeting, June 3-8, 2023, Toronto, 2023. Abstract No. 2958.
10. Tofts, Paul S., et al. "Estimating kinetic parameters from dynamic contrast‐enhanced T1‐weighted MRI of a diffusable tracer: standardized quantities and symbols." Journal of Magnetic Resonance Imaging: An Official Journal of the International Society for Magnetic Resonance in Medicine 10.3 (1999): 223-232.
11. Omodaka, S., et al. "Quantitative assessment of circumferential enhancement along the wall of cerebral aneurysms using MR imaging." American Journal of Neuroradiology 37.7 (2016): 1262-1266.
Figure 1. The permeability of the non-saccular aneurysm wall is measured by DCE-MRI. The intracranial aneurysm is verified non-saccular by analysis of 3D TOF images (A), pre (B) and post-contrast (C) images. Plasma contrast agent concentration (Cp) and contrast agent concentration in the tissue surrounding the aneurysm wall (Ct) (D) are obtained by manually delineating regions of interest of Cp and Ct (E).
Table 1. Demographic information of the sample (N=42) and correlation with Ktrans. Categoric variables are summarized as count (percentage). The Kolmogorov-Smirnov test was used to test the existence of normal distribution for each continuous variable, and then the quantitative variables were expressed as mean ± SD or median (IQR). Spearman analysis show that there is no correlation between Ktrans and clinical factors, excepting IA size and PHASES score.
Figure 2. High enhancement of the non-saccular intracranial aneurysm wall with high or low Ktrans. Case 1: A 56-year-old female with 11.1 mm aneurysm. There is high aneurysm wall enhancement after injection of contrast, and DCE-MRI shows low aneurysm wall permeability. Case 2: A 56-year-old male with 22.0 mm aneurysm. Significant wall enhancement is observed, but DCE-MRI shows high aneurysm wall permeability. Case 1 also has smaller IA size and lower PHASES score than case 2.
Figure 3. Correlation between non-saccular aneurysm wall permeability and IA size (A) and PHASES score (B). Spearman correlation analysis show that Ktrans correlates with IA size (ρ = 0.386, P = .012) and PHASES score (ρ = 0.323, P = .037).
Figure 4. Associations between non-saccular aneurysm wall permeability and IMH (A) and WEI (B). Spearman analysis show that Ktrans has no significant correlation with IMH (P = .324) and WEI (P = .091).